SFM
HALO icon

Sphera Funds Management’s Halozyme HALO Stock Holding History

Sphera Funds Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-135,000
Closed -$2.34M – 103
2015
Q4 		$2.34M Sell
135,000
-15,000
-10% -$239K 0.34% 73
2015
Q3 		$2.02M Hold
150,000
– – 0.26% 93
2015
Q2 		$3.39M Buy
+150,000
New +$2.64M 0.33% 74

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sphera Funds Management's HALO Position: Q1 2016 in Review

Sphera Funds Management sold out of Halozyme (HALO) in Q1 2016, closing a stake of 135,000 shares — an estimated $2.34M sold.

Sphera Funds Management first reported a position in HALO in Q2 2015 and held it in 3 quarters. The position peaked at $3.39M in Q2 2015. 161 funds tracked by Wall St. Rank hold HALO as of Q1 2016.

  • Sphera Funds Management reported no remaining Halozyme position as of Q1 2016 after selling out during the quarter.
  • Sphera Funds Management sold 135,000 Halozyme shares in Q1 2016, an estimated $2.34M.
  • Sphera Funds Management first reported a position in Halozyme in Q2 2015 and held it in 3 quarters.
  • Sphera Funds Management's Halozyme position peaked at $3.39M in Q2 2015.
  • 161 funds tracked by Wall St. Rank held Halozyme as of Q1 2016.

Based on Sphera Funds Management's 13F filing for Q1 2016, filed 16 May 2016.